Effect of Problematic Smartphone Use
NCT06636929 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 131
Last updated 2026-03-10
Summary
There is no study that examines the effect of problematic use of smartphones, which has become a global problem today, on reaction time and cognitive functions together. This study was planned to examine the effect of problematic smartphone use on upper extremity functions and cognitive functions. Participants' problematic smartphone use will be evaluated with the Smartphone Addiction Scale Short Form. Within the scope of upper extremity functions, Quick Disabilities of Arm, Shoulder \& Hand Questionnaire, reaction time and grip strength will be evaluated. Reaction time will be measured with BlazePod Trainer (Blazepod Trainer Device, Play Coyotta Ltd, Tel Aviv, Israel). Jamar dynamometer (Performance Health, Warrenville, IL) will be used to evaluate grip strength. Cognitive functions will be assessed using the Stroop Test ÇAPA Form, Trail Making Test and Cognitive Failures Questionnaire.
Conditions
- Smartphone Addiction
Sponsors & Collaborators
-
Kutahya Health Sciences University
lead OTHER
Principal Investigators
-
Ismail Okur, PT, PhD · Kutahya Health Sciences University
Eligibility
- Min Age
- 18 Years
- Max Age
- 25 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-10-20
- Primary Completion
- 2025-06-30
- Completion
- 2025-12-31
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Study of the Effects of MDMA/Ecstasy on Water Regulation, Sleep, and Cognition.
NCT01053403 ·Status: COMPLETED ·Phase: NA
-
Investigating the Acute Effects of THC on Functional Brain Systems
NCT00628706 ·Status: COMPLETED ·Phase: PHASE1
-
Dual Orexin Antagonism and Emotion and Affective Processing Study
NCT07267559 ·Status: RECRUITING ·Phase: PHASE4
-
Pharmacological Cognitive Enhancement
NCT01684306 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Examining the Role of Tolerance on Dose-dependent Effects of Acute THC on Oculomotor and Cognitive Performance
NCT06351540 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Developing a Mobile Method to Measure THC-induced Impairment
NCT03804840 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
MDMA in Borderline Personality Disorder
NCT06683014 ·Status: RECRUITING ·Phase: PHASE2
-
Outcomes of Antipsychotic Medication Used in the Emergency Department
NCT02504450 ·Status: COMPLETED
-
Neurochemical Modulation Cognitive Performance and Subjective Wellbeing In Healthy Controls
NCT02051153 ·Status: COMPLETED ·Phase: NA
-
Cognitive Hyper-performance - Effects of Stimulating Substances in Chess-players
NCT01834547 ·Status: COMPLETED ·Phase: PHASE1
-
French Study on COgnitive Enhancement and Consumption of Psychoactive Substances Among Youth Students
NCT02954679 ·Status: COMPLETED
-
Effects of Stimulants on Behavioral and Neural Markers of Social Motivation, Ability, and Neural Markers of Social Function
NCT05379959 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Prevalence of Behavioral Addiction and Its Relation With Psychological Disturbance
NCT07174700 ·Status: ACTIVE_NOT_RECRUITING
-
Acute Effects of Cannabis on Everyday Life Memory
NCT05488509 ·Status: COMPLETED ·Phase: PHASE2
-
Registration of Tobacco, Coffee and Substance Use Among Acutely Admitted Psychiatric Patients
NCT00184184 ·Status: COMPLETED
-
Effects of Drugs on Responses to Brain and Emotional Processes
NCT04053036 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Dopamine and Opioid Receptor Antagonists Reduce Cue-induced Reward Responding and Reward Impulsivity
NCT02557984 ·Status: COMPLETED ·Phase: NA
-
Systemic Ketamine for the Improvement of Post-Operative Analgesia at the Alcohol-Dependent Patient
NCT00329394 ·Status: SUSPENDED ·Phase: PHASE3
-
Double-Blind Naltrexone in Kleptomania
NCT00332579 ·Status: COMPLETED ·Phase: PHASE2
-
Explorative Efficacy Profile of Neurexan® in an Experimental Acute Stress Setting in Healthy Subjects
NCT01703819 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of Hallucinogens and Other Drugs on Mood and Performance
NCT02033707 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of a Mobile Phone Application Measuring the Eyes Before and After Medication
NCT06629740 ·Status: COMPLETED ·Phase: NA
-
Endocrine and Emotional Effects of Lisdexamfetamine and d-Amphetamine.
NCT02668926 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacovigilance in Gerontopsychiatric Patients
NCT02374567 ·Status: TERMINATED ·Phase: PHASE3
-
Oxytocin and Social Cognition
NCT01606462 ·Status: COMPLETED ·Phase: PHASE1